0EVI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 1.593 EUR -2.63% Market Closed

Market Cap: €129m

	Innate Pharma SA LSE:0EVI	FR
	Turk Hava Yollari AO F:TU5A	TR
P	Powerhouse Energy Group PLC SWB:BT81	UK
A	AT & S Austria Technologie & Systemtechnik AG XMUN:AUS	AT
S	Sunnova Energy International Inc F:7SE	US
H	Home BancShares Inc XBER:H5C	US
	MSP Steel & Power Ltd NSE:MSPL	IN
	Virgin Money UK PLC LSE:VMUK	UK
P	Powerhouse Energy Group PLC F:BT81	UK
I	Isgec Heavy Engineering Ltd BSE:533033	IN
	Perpetual Ltd OTC:PPTTF	AU
W	Webus International Ltd NASDAQ:WETO	CN
L	Lisi SA SWB:LI3	FR

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

67%

Declining Gross Margin

93% > 1%

Negative Operating Margin

-1 834%

Negative 3Y Average Operating Margin

-570%

Declining Operating Margin

-33% > -1 834%

Negative Net Margin

-1 765%

Negative 3Y Average Net Margin

-537%

Declining Net Margin

-117% > -1 765%

Negative Free Cash Flow Margin

-1 898%

Negative 3Y Average Free Cash Flow Margin

-478%

Declining Free Cash Flow Margin

-41% > -1 898%

Exceptional ROE

764%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-221%

Declining ROIC

-15% > -835%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.